Wikidata

(Q63322200)

English

Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies

clinical trial

In more languages

Statements

short name
PASSAGE (English)
0 references
title
Long-term, Prospective,Multinational, Parallel-cohort Study Monitoring Safety in Patients With MS Newly Started With Fingolimod Once Daily or Treated With Another Approved Disease-modifying Therapy (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
sponsor
Novartis
0 references
country
Argentina
0 references
Australia
0 references
Canada
0 references
Chile
0 references
Mexico
0 references
start time
1 August 2011
0 references
end time
26 December 2022
0 references
number of participants
3,620
0 references
research site
Novartis
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63322200&oldid=1857140921"